Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness

NCT01667952 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT01667952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01667952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Completed
Start date
August 31, 2012
Completion date
March 6, 2025
Enrollment
1,068 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric or young adult cancer survivors